2025
- What information is available on the use of omalizumab for IgE-mediated food allergy?
- What evidence evaluates the use of Paxlovid™ (nirmatrelvir/ritonavir) in severe renal impairment?
- What guidelines are available about ketamine use in the management of complex regional pain syndrome?
- What are the recommendations to identify and manage Shoulder Injury Related to Vaccine Administration (SIRVA)?
- Is there evidence to support initiation of remdesivir after 7 days in hospitalized patients with severe COVID-19?
- Is there literature, specifically guidelines, available on how to medically manage adverse reactions associated with intravenous iron?
- Is there evidence supporting the use of remdesivir for longer than 10 days in the treatment of COVID-19?
- What are the latest guideline recommendations for the treatment of Helicobacter pylori infection in the U.S.?
- What information is available regarding the new antipsychotic xanomeline/trospium?